247 related articles for article (PubMed ID: 34943972)
1. The Role of Chaperone-Mediated Autophagy in Bortezomib Resistant Multiple Myeloma.
Nikesitch N; Rebeiro P; Ho LL; Pothula S; Wang XM; Khong T; Quek H; Spencer A; Lee CS; Roberts TL; Ling SCW
Cells; 2021 Dec; 10(12):. PubMed ID: 34943972
[No Abstract] [Full Text] [Related]
2. Inhibition of chaperone‑mediated autophagy reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer.
Xuan Y; Zhao S; Xiao X; Xiang L; Zheng HC
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760140
[TBL] [Abstract][Full Text] [Related]
3. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
[TBL] [Abstract][Full Text] [Related]
4. Chaperone-mediated autophagy affects tumor cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.
Cao D; Shan D; Yan W; Zhang Z; Song Q; Jiang Y; Zhang X; Zhang Z; Wang Z; Wang Y; Lu S
Thorac Cancer; 2021 Apr; 12(7):1048-1057. PubMed ID: 33566442
[TBL] [Abstract][Full Text] [Related]
5. Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment.
Adomako A; Calvo V; Biran N; Osman K; Chari A; Paton JC; Paton AW; Moore K; Schewe DM; Aguirre-Ghiso JA
BMC Cancer; 2015 May; 15():444. PubMed ID: 26025442
[TBL] [Abstract][Full Text] [Related]
6. Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma.
Abdel Malek MA; Jagannathan S; Malek E; Sayed DM; Elgammal SA; Abd El-Azeem HG; Thabet NM; Driscoll JJ
Oncotarget; 2015 Feb; 6(5):3098-110. PubMed ID: 25605012
[TBL] [Abstract][Full Text] [Related]
7. TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition.
Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
Cell Cycle; 2016; 15(4):559-72. PubMed ID: 26743692
[TBL] [Abstract][Full Text] [Related]
8. Chaperone-mediated autophagy receptor modulates tumor growth and chemoresistance in non-small cell lung cancer.
Ichikawa A; Fujita Y; Hosaka Y; Kadota T; Ito A; Yagishita S; Watanabe N; Fujimoto S; Kawamoto H; Saito N; Yoshida M; Hashimoto M; Minagawa S; Hara H; Motoi N; Yamamoto Y; Ochiya T; Araya J; Kuwano K
Cancer Sci; 2020 Nov; 111(11):4154-4165. PubMed ID: 32860290
[TBL] [Abstract][Full Text] [Related]
9. NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma.
Huang J; Zhou Y; Thomas GS; Gu Z; Yang Y; Xu H; Tricot G; Zhan F
Clin Cancer Res; 2015 Dec; 21(24):5532-42. PubMed ID: 26156395
[TBL] [Abstract][Full Text] [Related]
10. ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy.
Zhang H; Pang Y; Ma C; Li J; Wang H; Shao Z
Oncol Res; 2018 Apr; 26(3):421-429. PubMed ID: 28899456
[TBL] [Abstract][Full Text] [Related]
11. Reduced response of IRE1α/Xbp-1 signaling pathway to bortezomib contributes to drug resistance in multiple myeloma cells.
Xu X; Liu J; Huang B; Chen M; Yuan S; Li X; Li J
Tumori; 2017 May; 103(3):261-267. PubMed ID: 27647225
[TBL] [Abstract][Full Text] [Related]
12. Discovery of LAMP-2A as potential biomarkers for glioblastoma development by modulating apoptosis through N-CoR degradation.
Wang Y; Zhang B; Wang J; Wu H; Xu S; Zhang J; Wang L
Cell Commun Signal; 2021 Mar; 19(1):40. PubMed ID: 33761934
[TBL] [Abstract][Full Text] [Related]
13. Chaperone-mediated autophagy protects cardiomyocytes against hypoxic-cell death.
Ghosh R; Gillaspie JJ; Campbell KS; Symons JD; Boudina S; Pattison JS
Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1555-C1575. PubMed ID: 35584327
[TBL] [Abstract][Full Text] [Related]
14. Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells.
Moriya S; Che XF; Komatsu S; Abe A; Kawaguchi T; Gotoh A; Inazu M; Tomoda A; Miyazawa K
Int J Oncol; 2013 May; 42(5):1541-50. PubMed ID: 23546223
[TBL] [Abstract][Full Text] [Related]
15. Impaired degradation of YAP1 and IL6ST by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells.
Desideri E; Castelli S; Dorard C; Toifl S; Grazi GL; Ciriolo MR; Baccarini M
Autophagy; 2023 Jan; 19(1):152-162. PubMed ID: 35435804
[TBL] [Abstract][Full Text] [Related]
16. XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma.
Turner JG; Kashyap T; Dawson JL; Gomez J; Bauer AA; Grant S; Dai Y; Shain KH; Meads M; Landesman Y; Sullivan DM
Oncotarget; 2016 Nov; 7(48):78896-78909. PubMed ID: 27806331
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
18. Increased LAMP2A levels correlate with a shorter disease-free survival of HER2 negative breast cancer patients and increased breast cancer cell viability.
Tokarchuk I; Janser FA; Schläfli AM; Pinto MT; Humbert M; Niklaus NJ; Berezowska S; Langer R; Tschan MP
Biochem Biophys Res Commun; 2021 Sep; 569():47-53. PubMed ID: 34229122
[TBL] [Abstract][Full Text] [Related]
19. Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity.
Auzmendi-Iriarte J; Otaegi-Ugartemendia M; Carrasco-Garcia E; Azkargorta M; Diaz A; Saenz-Antoñanzas A; Andermatten JA; Garcia-Puga M; Garcia I; Elua-Pinin A; Ruiz I; Sampron N; Elortza F; Cuervo AM; Matheu A
Cancer Res; 2022 Apr; 82(7):1283-1297. PubMed ID: 35131870
[TBL] [Abstract][Full Text] [Related]
20. Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma.
Salem K; McCormick ML; Wendlandt E; Zhan F; Goel A
Redox Biol; 2015; 4():23-33. PubMed ID: 25485927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
